Will Aurion Biotech’s IPO Survive a Legal Storm? Discover the Eye-Catching Details
Aurion Biotech plans to IPO on the New York Stock Exchange under the ticker "AURN." Challenges include a lawsuit from Alcon Research alleging violations of shareholder rights. Aurion countersued, accusing…
Groundbreaking Immunotherapy Insights Unveiled: Don’t Miss Eledon Pharmaceuticals’ Upcoming Fireside Chat
Eledon Pharmaceuticals is based in Irvine, California, and focuses on immune-modulating therapies. Dr. David-Alexandre C. Gros and Dr. Steve Perrin will host a fireside chat on February 5th at the…
Mark Your Calendars: ANI Pharmaceuticals to Shine at Guggenheim Biotech Conference
Get ready for an exciting peek into the future of pharmaceuticals! On February 5, 2025, ANI Pharmaceuticals, Inc. will take center stage at the illustrious Guggenheim Biotech Conference in New…
Unlock the Secrets of Biotech Investing! Discover XBI Now
Investing in Biotech: The XBI Opportunity The SPDR S&P Biotech ETF, known by its ticker XBI, stands out as a prime investment vehicle within the U.S. biotechnology landscape. Managed by…
Revolutionizing Cancer Treatment: The Future Is Here! Discover How AI is Changing the Game
**Innovation Takes a Leap Forward** Angelos Stergiou, CEO of SELLAS Life Sciences, has revealed that his team is on the verge of completing a groundbreaking leukemia vaccine. But that's just…
Massive Investment Fuels Cancer Drug Innovation
Ascentage Pharma, a key player in the global pharmaceutical landscape, has recently secured an impressive $126.4 million through a U.S. IPO. This substantial funding is primarily earmarked for the advanced…
Trump’s Bold Move: What It Means for Global Health! Are U.S. Firms Afraid of China?
In this week's episode of the engaging biotech podcast “The Readout LOUD,” critical issues in health and drug development take center stage. The conversation kicks off with reflections on the…
Biogen’s Bold Move: Leadership Changes and Workforce Cuts Ahead
Restructuring Within Biogen's Research Division In a strategic shift following a challenging year, Biogen’s newly appointed research leader, Jane Grogan, Ph.D., is implementing significant adjustments to the company's research team.…
Is Biotechnology the New Battlefield? The U.S. Takes Action
The technological race between the United States and China intensifies as the U.S. imposes strict export controls on biotechnology. The Department of Commerce has implemented new rules aimed at safeguarding…
BNN Faces Setbacks: Revenue Declines and Losses Widening
**A rough year for BRAIN Biotech has resulted in declining revenue and increasing net losses.** The company reported a revenue of €55.5 million for the fiscal year, reflecting a minor…